Treatment of allergic rhinitis using a combination of mometasone and olopatadine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10646500
APP PUB NO 20150099725A1
SERIAL NO

14506122

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present patent application relates to a method of treating allergic rhinitis in a subject (preferably a human) by administering a combination of mometasone or its salt and olopatadine or its salt.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GLENMARK SPECIALTY S.A.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Agarwal, Piyush Mumbai, IN 57 260
Bhosale, Vikram Mansingh Mumbai, IN 6 42
Keohane, Patrick London, GB 14 56
Khairatkar-Joshi, Neelima Thane, IN 58 205
Kulkarni, Abhay Navi Mumbai, IN 42 821
Oh, Chad Mahwah, US 12 24
Tantry, Sudeesh K Jamison, US 10 24
Wale, Dinesh Pradeep Osmanabad, IN 12 34

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 12, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 12, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00